Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | AZN | AMGN | GILD | BMY |
| Company | Inhibrx Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 105.84 | 188.26 | 340.56 | 135.25 | 59.62 |
| High | 106.94 | 188.61 | 342.49 | 136.32 | 59.78 |
| Low | 99.20 | 186.94 | 335.83 | 134.29 | 58.10 |
| Latest | 105.76 | 187.09 | 336.42 | 134.84 | 58.25 |
| Change | +4.44 | +0.06 | -2.88 | +0.48 | -1.21 |
| % Change | +4.38% | +0.03% | -0.85% | +0.36% | -2.03% |
| Volume | 136,917 | 859,176 | 662,293 | 2,952,688 | 3,786,294 |
| 20-Day Average Volume | 536,427 | 1,987,975 | 2,689,447 | 5,973,383 | 10,082,448 |
| Previous Close | 101.32 | 187.03 | 339.30 | 134.36 | 59.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 119.51 | 185.01 | 333.18 | 132.12 | 57.58 |
| 20-Day Raw Stochastic | 9.32% | 66.61% | 54.72% | 75.21% | 52.65% |
| 20-Day Relative Strength | 49.57 | 48.25 | 47.57 | 51.30 | 50.49 |
| Weighted Alpha | +203.47 | +24.46 | +13.95 | +20.38 | +22.21 |
| Today's Opinion | 80% Buy | 8% Buy | 8% Sell | 8% Buy | 40% Buy |
| Previous Opinion | 80% Buy | 8% Sell | 8% Sell | 8% Buy | 64% Buy |
| Last Month's Opinion | 88% Buy | 48% Buy | 8% Buy | 8% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.85% since 05/18/26 | +2.03% since 05/18/26 | +3.70% since 05/18/26 | +4.21% since 05/18/26 | +1.61% since 05/18/26 |
| Low | 99.00 on 05/22/26 | 184.19 on 05/19/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 57.08 on 05/19/26 |
| High | 113.95 on 05/20/26 | 191.50 on 05/21/26 | 343.80 on 05/22/26 | 136.15 on 05/26/26 | 60.25 on 05/22/26 |
| 1-Month | |||||
| %Chg | -19.54% since 04/24/26 | -1.10% since 04/24/26 | -2.37% since 04/24/26 | +3.63% since 04/24/26 | -0.81% since 04/24/26 |
| Low | 99.00 on 05/22/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 150.98 on 05/11/26 | 191.50 on 05/21/26 | 349.54 on 04/30/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +34.46% since 02/26/26 | -8.00% since 02/26/26 | -11.32% since 02/26/26 | -6.01% since 02/26/26 | -4.69% since 02/26/26 |
| Low | 57.30 on 03/27/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 155.29 on 04/22/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +24.13% since 11/26/25 | +0.55% since 11/26/25 | -2.37% since 11/26/25 | +5.98% since 11/26/25 | +18.24% since 11/26/25 |
| Low | 57.30 on 03/27/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 155.29 on 04/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,486,465 | 290,066,304 | 183,115,120 | 166,817,344 | 121,421,536 |
| Shares Outstanding, K | 14,671 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 1,300,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -140,060,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -33,440,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 3.88 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.15 on 05/14/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/12/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.49 | 15.27 | 15.59 | 10.04 |